169 related articles for article (PubMed ID: 22214766)
1. Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.
Wang X; Sistrunk C; Miliani de Marval PL; Kim Y; Rodriguez-Puebla ML
Cell Cycle; 2012 Jan; 11(2):335-42. PubMed ID: 22214766
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation.
Lee SH; Wang X; Kim SH; Kim Y; Rodriguez-Puebla ML
Oncol Lett; 2017 Sep; 14(3):2723-2734. PubMed ID: 28927034
[TBL] [Abstract][Full Text] [Related]
6. The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells.
Chaves-Ferreira M; Krenn G; Vasseur F; Barinov A; Gonçalves P; Azogui O; Cumano A; Li Z; Pellegrini S; Rocha B; Laderach D
Biol Direct; 2016 Apr; 11():21. PubMed ID: 27129404
[TBL] [Abstract][Full Text] [Related]
7. Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.
Wang H; Kumar TR
Gene Expr Patterns; 2012; 12(3-4):136-44. PubMed ID: 22289519
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.
Zhang Q; Sakamoto K; Liu C; Triplett AA; Lin WC; Rui H; Wagner KU
Cancer Res; 2011 Dec; 71(24):7513-24. PubMed ID: 22037875
[TBL] [Abstract][Full Text] [Related]
9. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y
Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of Akt signaling in mouse skin tumorigenesis.
Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
[TBL] [Abstract][Full Text] [Related]
11. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
12. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
13. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
14. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.
Sterlacci W; Fiegl M; Hilbe W; Jamnig H; Oberaigner W; Schmid T; Augustin F; Auberger J; Obermann EC; Tzankov A
J Thorac Oncol; 2010 Sep; 5(9):1325-36. PubMed ID: 20631637
[TBL] [Abstract][Full Text] [Related]
16. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
17. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo.
Robles AI; Rodriguez-Puebla ML; Glick AB; Trempus C; Hansen L; Sicinski P; Tennant RW; Weinberg RA; Yuspa SH; Conti CJ
Genes Dev; 1998 Aug; 12(16):2469-74. PubMed ID: 9716400
[TBL] [Abstract][Full Text] [Related]
18. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
[TBL] [Abstract][Full Text] [Related]
19. STAT3 down-regulates the expression of cyclin D during liver development.
Matsui T; Kinoshita T; Hirano T; Yokota T; Miyajima A
J Biol Chem; 2002 Sep; 277(39):36167-73. PubMed ID: 12147685
[TBL] [Abstract][Full Text] [Related]
20. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
